TUG1在骨肉瘤发生发展中的作用的研究进展
DOI:
作者:
作者单位:

兰州大学

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金项目(面上项目,重点项目,重大项目)


Research progress on the role of TUG1 in the occurrence and development of osteosarcoma
Author:
Affiliation:

Lanzhou University

Fund Project:

The National Natural Science Foundation of China (General Program, Key Program, Major Research Plan)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    牛磺酸上调基因1 (Taurine upregulated 1, TUG1) 是一种长链非编码RNA (Long non-coding RNA, lncRNA),其通过复杂的分子机制参与骨肉瘤的发生发展。它通过抑制多种miroRNA (miRNA) 和调节相关信号通路,促进骨肉瘤细胞的增殖、侵袭和转移,抑制骨肉瘤细胞的凋亡。此外,TUG1的表达水平与骨肉瘤患者的预后相关,是一种判断预后的潜在生物标志物。本文旨在总结近年来的相关研究,对TUG1参与骨肉瘤细胞增殖、凋亡、侵袭和转移的相关分子机制,以及TUG1在骨肉瘤中的临床意义的研究进展做一综述。

    Abstract:

    Taurine upregulated gene 1 (TUG1) is a long non-coding RNA(lncRNA), which involves in the occurrence and development of osteosarcoma through complex molecular mechanisms. It can promote the proliferation, invasion and metastasis, and inhibit the apoptosis of osteosarcoma cells by inhibiting some miroRNAs (miRNAs) and regulating related signal pathways. In addition, the expression level of TUG1 is related to the prognosis of osteosarcoma patients, and TUG1 is a potential biomarker for prognosis. In this paper, by summarizing related studies in recent years,we review the molecular mechanisms of proliferation, apoptosis, invasion and metastasis in osteosarcoma cell mediated by TUG1 and the clinical value of TUG1 in osteosarcoma.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-03-17
  • 最后修改日期:2021-03-17
  • 录用日期:2021-07-20
  • 在线发布日期:
  • 出版日期: